HighGravityData
Companies / Equinix / Filing

Equinix — Oct 29, 2025 release

Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001101239-25-000061
Open on SEC.gov ↗
Showing in the filing
AFFO growth, normalized and constant currency
“11 - 13%”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 24
Revenues for FY2025
“$9,208 - 9,328”
Adjusted EBITDA Margin % for Q4 FY2025
“49 - 50%”
AFFO per Share (Diluted) for FY2025
“$37.95 - 38.77”
Non-recurring Capital Expenditures (includes… for FY2025
“$3,514 - 3,994”
Recurring Capital Expenditures % of revenues for FY2025
“~3%”
Recurring Capital Expenditures % of Revenues for Q4 FY2025
“6%”
Expected Cash Dividends for FY2025
“~$1,836”
Revenues for Q4 FY2025
“$2.411 and $2.531 billion”
Adjusted EBITDA for Q4 FY2025
“$1.187 and $1.267 billion”
Recurring capital expenditures for Q4 FY2025
“$134 and $154 million”
Total revenues for FY2025
“$9.208 and $9.328 billion”
Total revenues growth, as-reported for FY2025
“approximately 5 - 7%”
Total revenues growth, normalized and consta… for FY2025
“approximately 7 - 8%”
Adjusted EBITDA for FY2025
“$4.531 and $4.611 billion”
Adjusted EBITDA margin for FY2025
“49%”
AFFO for FY2025
“$3.731 and $3.811 billion”
AFFO growth, as-reported for FY2025
“11 - 14%”
AFFO growth, normalized and constant currency for FY2025
“11 - 13%”
AFFO per share growth, as-reported for FY2025
“8 - 11%”
AFFO per share growth, normalized and consta… for FY2025
“8 - 10%”
Total capital expenditures for FY2025
“$3.792 and $4.292 billion”
Non-recurring capital expenditures for FY2025
“$3.514 and $3.994 billion”
On-balance-sheet xScale-related spend for FY2025
“approximately $450 million”
Recurring capital expenditures for FY2025
“$278 and $298 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
This updated guidance includes an underlying raise of $21 million from better-than-expected business performance, partially offset by a $7 million negative foreign currency impact when compared to prior guidance. AFFO 5 is expected to range between $3.731 and $3.811 billion, an increase of 11 - 14% over the previous year on an as-reported basis, or 11 - 13% on a normalized and constant currency basis. This updated guidance includes an underlying raise of $31 million from better-than-expected business performance and strong balance sheet management, partially offset by a $3 million negative foreign currency impact when compared to prior guidance rates. AFFO per share is expected to range between $37.95 and $38.77, an 8 - 11% as-reported increase over the previous year, or 8 - 10% on a normalized and constant currency basis. Total capital expenditures are expected to range between $3.792 and $4.292 billion. This includes non-recurring capital expenditures of between $3.514 and $3.994 billion and approximately $450 million of on-balance-sheet xScale-related spend, which we expect to be reimbursed as we transfer assets into our joint ventures. Recurring capital expenditures are expected to range between $278 and $298 million. The U.S. dollar exchange rates used for 2025 guidance, taking into consideration the impact of our current foreign currency hedges, have been updated to $1.13 to the Euro, $1.29 to the British Pound, S$1.29 to the U.S. Dollar, ¥148 to the U.S. Dollar, A$1.51 to the U.S. Dollar, HK$7.78 to the U.S. Dollar, R$5.32 to
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.